Stemcell Technologies Inc. makes more than 1,500 types of tissue culture media, the crucial tools for harvesting and growing stem cells, and sells them to laboratories and hospitals in more than 70 countries around the world.
As such, the Vancouver biotechnology company is one of the key players in the burgeoning field of regenerative medicine, a quiet behind-the-curtain player in a field that has the potential to revolutionize health care with cures for everything from cancer to spinal-cord injury.